Advanced search
Publication Cover
Blood Pressure Volume 14, 2005 - Issue 4
Submit an article Journal homepage
266
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Reduced nitric oxide levels in acromegaly: cardiovascular implications

Vanessa Ronconi Division of Endocrinology, Department of Internal Medicine, Università Politecnica delle Marche, Ospedali Riuniti Umberto I‐GM Lancisi‐G Salesi, Ancona, Italy
,
Gilberta Giacchetti Division of Endocrinology, Department of Internal Medicine, Università Politecnica delle Marche, Ospedali Riuniti Umberto I‐GM Lancisi‐G Salesi, Ancona, ItalyCorrespondence[email protected]
,
Barbara Mariniello Division of Endocrinology, Department of Medical and Surgical Sciences, University of Padua, Italy
,
Andrea Camilletti Division of Endocrinology, Department of Internal Medicine, Università Politecnica delle Marche, Ospedali Riuniti Umberto I‐GM Lancisi‐G Salesi, Ancona, Italy
,
Franco Mantero Division of Endocrinology, Department of Medical and Surgical Sciences, University of Padua, Italy
,
Marco Boscaro Division of Endocrinology, Department of Internal Medicine, Università Politecnica delle Marche, Ospedali Riuniti Umberto I‐GM Lancisi‐G Salesi, Ancona, Italy
,
Arianna Vignini Institute of Biochemistry, Università Politecnica delle Marche, Ancona, Italy
&
Laura Mazzanti Institute of Biochemistry, Università Politecnica delle Marche, Ancona, Italy
 show all
Pages 227-232 | Received 31 Jan 2005, Accepted 21 Mar 2005, Published online: 08 Jul 2009

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Sean C. Newton & Shelly Marshall. (2021) Effects of anodyne treatment on local blood flow and cutaneous sensation of the foot in a patient with peripheral neuropathy secondary to acromegaly. Physiotherapy Theory and Practice 37:5, pages 655-662.
Read now
N. Wiernsperger, P. Nivoit, L. G. Kraemer De Aguiar & E. Bouskela. (2007) Microcirculation and the Metabolic Syndrome. Microcirculation 14:4-5, pages 403-438.
Read now

Articles from other publishers (20)

Gabriela Mihai & Márta Korbonits. 2023. Endocrine Hypertension. Endocrine Hypertension 217 247 .
Gianmaria Salvio, Marianna Martino, Giancarlo Balercia & Giorgio Arnaldi. (2022) Acromegaly and male sexual health. Reviews in Endocrine and Metabolic Disorders 23:3, pages 671-678.
Crossref
Gianmaria Salvio, Marianna Martino, Giulia Giancola, Giorgio Arnaldi & Giancarlo Balercia. (2021) Hypothalamic–Pituitary Diseases and Erectile Dysfunction. Journal of Clinical Medicine 10:12, pages 2551.
Crossref
Han Yang, Huiwen Tan, He Huang & Jianwei Li. (2021) Advances in Research on the Cardiovascular Complications of Acromegaly. Frontiers in Oncology 11.
Crossref
Thalijn L. C. Wolters, Mihai G. Netea, Niels P. Riksen, Adrianus R. M. M. Hermus & Romana T. Netea-Maier. (2020) Acromegaly, inflammation and cardiovascular disease: a review. Reviews in Endocrine and Metabolic Disorders 21:4, pages 547-568.
Crossref
Soraya Puglisi & Massimo Terzolo. (2019) Hypertension and Acromegaly. Endocrinology and Metabolism Clinics of North America 48:4, pages 779-793.
Crossref
Pinar Sisman, Murat Pekgoz, Ismail Bayrakci, Mete Sisman, Soner Cander, Ozen Oz Gul, Erdinc Erturk & Canan Ersoy. (2019) Evaluation of upper gastrointestinal system in acromegaly. Annales d'Endocrinologie 80:4, pages 196-201.
Crossref
Zhengyuan Chen, Yifei Yu, Min He, Ming Shen, Wei Gong, Meng Wang, Yeping Yang, Yichao Zhang, Xuefei Shou, Yongning Lu, Nianqin Yang, Xiaoyun Cao, Shiqi Li, Yiming Li, Yao Zhao, Yongfei Wang, Jian Cai & Zhaoyun Zhang. (2019) Higher Growth Hormone Levels are Associated with Erectile Dysfunction in Male Patients With Acromegaly. Endocrine Practice 25:6, pages 562-571.
Crossref
Ana M. Ramos-Leví & Mónica Marazuela. (2019) Bringing Cardiovascular Comorbidities in Acromegaly to an Update. How Should We Diagnose and Manage Them?. Frontiers in Endocrinology 10.
Crossref
Rosario Pivonello, Renata S. Auriemma, Ludovica F. S. Grasso, Claudia Pivonello, Chiara Simeoli, Roberta Patalano, Mariano Galdiero & Annamaria Colao. (2017) Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary 20:1, pages 46-62.
Crossref
Marianna Yaron, Elena Izkhakov, Jessica Sack, Ibrahim Azzam, Etty Osher, Karen Tordjman, Naftali Stern & Yona Greenman. (2016) Arterial properties in acromegaly: relation to disease activity and associated cardiovascular risk factors. Pituitary 19:3, pages 322-331.
Crossref
Daniel H. P. Towie & George R. Merriam. 2013. Endocrine Hypertension. Endocrine Hypertension 151 179 .
S. N. Boysan, F. Kantarci, O. Celik, I. Mihmanli, N. Gazioglu & Pinar Kadioglu. (2012) Atherosclerotic Risk Factors and Premature Atherosclerosis in Acromegaly Before and After 48 Months of Octreotide-LAR Treatment. Angiology 63:7, pages 522-527.
Crossref
Justin P. ZachariahVanessa XanthakisMartin G. LarsonJoseph A. VitaLisa M. SullivanHolly M. SmithRadwan SafaXuyang PengNaomi HamburgDaniel LevyDouglas B. SawyerGary F. MitchellRamachandran S. Vasan. (2012) Circulating Vascular Growth Factors and Central Hemodynamic Load in the Community. Hypertension 59:4, pages 773-779.
Crossref
Ä°. Kartal, H. Oflaz, B. Pamukçu, M. MeriçF. Aral, N. ÃZbey & F. Alagöl. (2010) Investigation of early atherosclerotic changes in acromegalic patients. International Journal of Clinical Practice 64:1, pages 39-44.
Crossref
Michael R. Graham, Peter Evans, Non-Eleri Thomas, Bruce Davies & Julien S. Baker. (2009) Changes in Endothelial Dysfunction and Associated Cardiovascular Disease Morbidity Markers in GH-IGF Axis Pathology. American Journal Cardiovascular Drugs 9:6, pages 371-381.
Crossref
Malgorzata Karbownik-Lewinska, Agnieszka Kokoszko, Krzysztof C. Lewandowski, Stephen M. Shalet & Andrzej Lewinski. (2008) GH replacement reduces increased lipid peroxidation in GH-deficient adults. Clinical Endocrinology 68:6, pages 957-964.
Crossref
Laurence Katznelson. (2007) Current thinking on the management of the acromegalic patient. Current Opinion in Endocrinology, Diabetes & Obesity 14:4, pages 311-316.
Crossref
Michael R. Graham, Julien S. Baker, Peter Evans, Andrew Kicman, David Cowan, David Hullin & Bruce Davies. (2007) Evidence for a decrease in cardiovascular risk factors following recombinant growth hormone administration in abstinent anabolic-androgenic steroid users. Growth Hormone & IGF Research 17:3, pages 201-209.
Crossref
Patrick Maison, Anne-Isabelle Tropeano, Isabelle Macquin-Mavier, Andrea Giustina & Philippe Chanson. (2007) Impact of Somatostatin Analogs on the Heart in Acromegaly: A Metaanalysis. The Journal of Clinical Endocrinology & Metabolism 92:5, pages 1743-1747.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.